Vaxart Inc. (VXRT): Price and Financial Metrics


Vaxart Inc. (VXRT)

Today's Latest Price: $9.19 USD

0.10 (1.10%)

Updated Aug 7 12:00am

Add VXRT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 344 in Biotech

See all "A" rated Strong Buy stocks

VXRT Stock Summary

  • Vaxart Inc's market capitalization of $5,872,293 is ahead of just 3.56% of US-listed equities.
  • The volatility of Vaxart Inc's share price is greater than that of 97.62% US stocks with at least 200 days of trading history.
  • Vaxart Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -160.86%, greater than the shareholder yield of just 2.65% of stocks in our set.
  • Visit VXRT's SEC page to see the company's official filings. To visit the company's web site, go to www.vaxart.com.
VXRT Daily Price Range
VXRT 52-Week Price Range

VXRT Stock Price Chart Technical Analysis Charts


VXRT Price/Volume Stats

Current price $9.19 52-week high $17.49
Prev. close $9.10 52-week low $0.25
Day low $9.19 Volume 13,781,800
Day high $10.20 Avg. volume 16,462,148
50-day MA $7.57 Dividend yield N/A
200-day MA $2.87 Market Cap 1.00B

Vaxart Inc. (VXRT) Company Bio


Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.





VXRT Latest News Stream


Event/Time News Detail
Loading, please wait...

VXRT Latest Social Stream


Loading social stream, please wait...

View Full VXRT Social Stream

Latest VXRT News From Around the Web

Below are the latest news stories about Vaxart Inc that investors may wish to consider to help them evaluate VXRT as an investment opportunity.

Vaxart raises ~$90M via at-the-market facility

With participation based on interest received from RA Capital Management and Invus, Vaxart ([[VXRT]] +59.3%) raised ~$90M in gross proceeds through its At-the-Market ((ATM)) facility.The clinical-stage biotechnology company sold ~11.2M shares at $7.98/share.The additional funds will support the clinical and pre-clinical development of Vaxart’s product candidates, to manufacture its products, and...

Seeking Alpha | July 13, 2020

Vaxart's Technology Could Be A COVID-19 Game Changer

Vaxart (VXRT) has soared over 2,000% YTD amid an acceptance to the Russell 3000, joining Operation Warp Speed, and the possibility of an effective COVID-19 'tablet' vaccine. The COVID-19 hype in other small-cap, speculative vaccine players like Novavax (NVAX), Inovio (INO), and Sorrento Therapeutics (SRNE) has fueled similar strong rallies....

Damien Robbins on Seeking Alpha | July 6, 2020

Read More 'VXRT' Stories Here

VXRT Price Returns

1-mo 12.21%
3-mo 260.39%
6-mo 678.81%
1-year 1,231.88%
3-year 36.96%
5-year -65.76%
YTD 2,521.97%
2019 -81.36%
2018 -70.02%
2017 -53.66%
2016 -36.60%
2015 -13.39%

Continue Researching VXRT

Here are a few links from around the web to help you further your research on Vaxart Inc's stock as an investment opportunity:

Vaxart Inc (VXRT) Stock Price | Nasdaq
Vaxart Inc (VXRT) Stock Quote, History and News - Yahoo Finance
Vaxart Inc (VXRT) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7876 seconds.